halofuginone has been researched along with Cardiac Failure in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arabacilar, P; Bantscheff, M; Bao, W; Bergamini, G; Bernard, RE; Del Rosario, J; Eisennagel, SH; Faelth Savitski, M; Force, TL; Gatto, GJ; Guo, Y; Halsey, WS; Hu, E; Hughes, AM; Joberty, G; Kirkpatrick, RB; Lal, H; Livi, GP; Lu, Q; Nayal, M; Olzinski, AR; Platchek, MC; Qin, P; Qu, XA; Quaile, MP; Rajpal, DK; Roethke, T; Sathe, GM; Schnackenberg, CG; Willette, RN; Wright, F; Xie, W | 1 |
1 other study(ies) available for halofuginone and Cardiac Failure
| Article | Year |
|---|---|
Activation of the Amino Acid Response Pathway Blunts the Effects of Cardiac Stress.
Topics: Amino Acids; Amino Acyl-tRNA Synthetases; Animals; Autophagy; Cells, Cultured; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fibroblasts; Fibrosis; Heart Failure; Humans; Hypertrophy, Left Ventricular; Induced Pluripotent Stem Cells; Male; Mice, Inbred C57BL; Myocytes, Cardiac; Piperidines; Protein Serine-Threonine Kinases; Protein Synthesis Inhibitors; Quinazolinones; Stress, Physiological; Time Factors; Ventricular Function, Left; Ventricular Remodeling | 2017 |